Our 40th anniversary event brought together scientists from all around the world, and now you can watch all of the sessions on demand.
Access inspiring keynotes, thought provoking presentations, career development workshops and more.
In honor of 40 years of scientific discovery, we’re talking to scientists from all over the world who have used our solutions to lay the groundwork for their history-defining breakthroughs, as well as the rising stars who are pushing the boundaries and tackling some of the most important unanswered questions facing genomics, today and into the future.
During his decades-long career in both academia and the private sector, Sir Peter Donnelly has applied his statistical and mathematical background to advancing the field of polygenic risk scores. "If we're successful... there will be millions of people alive in 20 to 30 years time who wouldn't be alive otherwise. That's how important it is."
Watch his full story to learn more.
University of Alberta
Dr. Kristi Baker shares how her lab uses both animal and human models for their research into colon cancer, in order to close the gap between bench and bedside.
Henry Bachrach Distinguished Professor, UCSF
Director, Institute of Biomedical Sciences, Academia Sinica
Pui Kwok discusses the Taiwan Precision Medicine Initiative, and the opportunities an challenges of integrating precision medicine into standard healthcare.
Weill Cornell Medicine
Dr. Barany is researching new liquid biopsy methods using cost efficient and scalable technology, in order to make cancer detection more accessible.
Consultant, Tata Memorial Hospital
Professor Anuradha Chougule is working to develop targeted, affordable cancer therapies that avoid the harmful sideeffectsofchemotherapy.
University of New Mexico
Professor Mellios shares how his research into circular RNA can help answer questions about psychiatric and neurological disorders such as bipolar disorder and schizophrenia.
Richard Pither and his company, Cytox, are utilizing polygenic risk scores to develop tests that might accurately identify a person's risk of developing Alzheimer's disease.
Head of Bioinformatics
Thermo Fisher Scientific
“What we do matters so much.” Jeanette Schmidt explains how being able to collaborate with customers and help them answer their research questions inspires her work in bioinformatics.
At Thermo Fisher Scientific, we know our Applied Biosystems instruments down to every detail. And our scientists understand your science. We’ve been at it for 40 years, and we’ll continue to be there every step of the way, partnering with you from breakthrough to discovery. Keep working wonders. We’ve got your back.
For Research Use Only. Not for use in diagnostic procedures.